1. At a Glance – The Curious Case of a 1938 Dinosaur That Forgot How to Run
Albert David Ltd is like that old Kolkata uncle who owns prime property, has a rich legacy, knows everyone in the industry… but somehow still complains about cash flow every Diwali.
On paper, this company looks like a solid, old-school pharmaceutical player. Founded in 1938, exporting to 35+ countries, WHO supplier, patented placenta-based drug (yes, placenta… we’ll come to that), strong distribution network, low debt, promoter holding above 62%.
Sounds like a hidden gem, right?
Now let’s ruin that fantasy.
Sales growth over 5 years? 1.5%
Profit growth? Negative
Operating margin? -0.63% (TTM)
ROE? 4.39%
ROCE? 6.45%
And just when you think it can’t get worse — FY25 profits crashed from ₹75 crore to ₹17 crore. That’s not a decline. That’s a financial faceplant.
Even the credit rating agency politely said: “Outlook: Negative” — which in corporate language means, “We’re not panicking yet… but we’re definitely watching.”
And if numbers weren’t enough, management exits started happening like contestants getting eliminated in Bigg Boss.
So the real question is:
Is this a turnaround story… or just a very slow-motion decline disguised as legacy?
2. Introduction – From Pharma Royalty to Margin Misery
Albert David is part of the Kothari Group — a diversified conglomerate with interests in tea, chemicals, textiles, and more.
Historically, this company was a respectable pharmaceutical player with niche strengths:
- Placenta-based formulations (Placentrex)
- IV fluids manufacturing
- Strong export footprint
- WHO supply contracts
But somewhere along the journey, growth decided to ghost them.
Let’s talk FY25:
- Revenue dropped to ₹345.77 crore (down ~5%)
- EBITDA margin collapsed from 13.12% → 1.17%
- PAT crashed from ₹75 crore → ₹17 crore
That’s not just a bad year — that’s a full operational breakdown.
Management says this happened because they spent more on marketing and expansion.
Translation:
“We spent money hoping for growth… but growth didn’t show up.”
Classic.
And then comes the cherry on top — multiple resignations:
